EligibleTrials

Clinical trials recruiting for Prostate Cancer Patients Treated by Radiotherapy

7
Recruiting trials
6
US states with sites
7
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 2 3Not applicable 4

Drugs and treatments being studied

InterventionTrials
External Beam Radiation Therapy (EBRT)1
Hypofractionated radiation with a microboost1
Pencil Beam Proton Therapy Treatment Machine1
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy (SIB-VMAT)1
aglatimagene besadenovec + valacyclovir1

Where trials are recruiting (top US states)

StateRecruiting trials
South Carolina2
Arizona1
Colorado1
Maryland1
Nevada1
New Jersey1

Top cities

Charleston, South Carolina 1Lakewood, Colorado 1Las Vegas, Nevada 1Littleton, Colorado 1Myrtle Beach, South Carolina 1Peoria, Arizona 1Saddle Brook, New Jersey 1Towson, Maryland 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Prostate Cancer Patients Treated by Radiotherapy often also study these conditions. Each links to its own recruiting-trial list.

Prostate cancer 1234Prostate Cancer (Diagnosis) 26Prostate Cancer (Adenocarcinoma) 43Prostate Cancer Recurrent 11Prostate Cancer (Post Prostatectomy) 14Prostate Cancer Metastatic 27

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Prostate Cancer Patients Treated by Radiotherapy trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.